Evidence map›Paper›PMID 41615646›Full record

SynthesisClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026

Deep learning for early diagnosis of uveal melanoma: a systematic review and meta-analysis.

Francisco Cezar Aquino de Moraes, Gustavo Tadeu Freitas Uchôa Matheus, Ísis Larissa de Brito Dichtl, Michele Kreuz, Emanuele Rocha da Silva, Rommel Mario Rodriguez Burbano

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Francisco Cezar Aquino de MoraesDepartment of Clinical and Toxicological Analyses, University of Sao Paulo, Sao Paulo, Sao Paulo, Brazil. francisco.cezar2205@gmail.com.ORCID http://orcid.org/0000-0003-0623-8135
Gustavo Tadeu Freitas Uchôa MatheusFederal University of Triângulo Mineiro, Uberaba, Minas Gerais, Brazil.ORCID http://orcid.org/0009-0005-8707-4823
Ísis Larissa de Brito DichtlFederal University of Piauí, Teresina, Piauí, Brazil.ORCID http://orcid.org/0009-0008-8245-8563
Michele KreuzLutheran University of Brazil, Canoas, Rio Grande Do Sul, Brazil.ORCID http://orcid.org/0009-0009-8968-8190
Emanuele Rocha da SilvaDepartment of Clinical and Toxicological Analyses, University of Sao Paulo, Sao Paulo, Sao Paulo, Brazil.ORCID http://orcid.org/0000-0002-9109-4158
Rommel Mario Rodriguez BurbanoHuman Cytogenetics Laboratory, Institute of Biological Sciences, Federal University of Pará, Belém, Pará, Brazil.ORCID http://orcid.org/0000-0002-4872-234X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUveal melanoma (UM) is a rare cancer with an estimated annual incidence of 6 incidences per million people. About half of UM patients develop distant metastases, mainly to the liver. After metastasis, prognosis is poor, with median survival under 1 year and limited treatment options. Thus, earlier diagnostic methods for UM are a critical unmet need. The aim of this study was to evaluate the accuracy (sensitivity, specificity, and combined F1 score) of deep learning algorithms in the differential diagnosis of individuals with uveal melanoma.

methodsWe searched PubMed, Scopus, and Web of Science for studies comparing UM patients to healthy individuals or those with ocular nevi using AI diagnostic tools. AI performance metrics were extracted, with clinical or expert-based assessment as the reference standard. The study adhered to PRISMA guidelines.

resultsFive studies comprising 6388 patients (2981 UM, 2563 nevi, and 844 healthy) were included. The mean age of UM patients ranged from 58 to 63.2 years; for nevi, from 58 to 66 years. Pooled sensitivity was 89.0% (95% CI 88.6-89.5%) with no heterogeneity (I

conclusionsWhile fundus imaging is widely used in outpatient care, multimodal imaging remains limited to specialized clinics. Developing software to analyze fundus images could improve early, noninvasive UM detection and offer a cost-effective diagnostic tool.

Indexed as

Deep LearningEarly Detection of CancerUveal MelanomaDiagnosis, DifferentialHumansSensitivity and SpecificityArtificial intelligenceDeep learningMeta-analysisUveal melanoma

Identifiers

PMID41615646
PMCPMC13282208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.